Resources

  • References


    Carter JR, Ding Z, et al. HPV infection and cervical disease: a review.
    Aust N Z J Obstet Gynaecol. 2011;51(2):103-108.


    Heffernan ME, Garland SM, et al. Global reduction of cervical cancer with
    human papillomavirus vaccines: insights from the hepatitis B virus vaccine
    experience.
    Sex Health. 2010;7(3):383-390.


    HPV vaccine (Cervarix): What you need to know. Centers for Disease Control and Prevention website. Available at:
    http://www.cdc.gov/vaccines/hcp/vis/vis-statements/hpv-cervarix.html. Updated May 5, 2011. Accessed May 31, 2013.


    HPV vaccine (Gardasil): What you need to know. Centers for Disease Control and Prevention website. Available at:
    http://www.cdc.gov/vaccines/hcp/vis/vis-statements/hpv-gardasil.html.
    Updated May 17, 2013. Accessed May 31, 2013.


    Human papillomavirus vaccine. EBSCO DynaMed website. Available at:
    https://dynamed.ebscohost.com/about/about-us. Updated May 7, 2013. Accessed May 31, 2013.


    Immunization schedules. Centers for Disease Control and Prevention website. Available at:
    http://www.cdc.gov/vaccines/schedules/index.html
    . Updated January 29, 2013. Accessed May 31, 2013.


    United States Centers for Disease Control and Prevention. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP).
    Morbidity and Mortality Weekly Report. 2010;59(20):630-632.


    Workowski KA, Berman S, Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines, 2010.
    MMWR.
    2010;59(No. RR-12):1-110.


    5/18/2007 DynaMed's Systematic Literature Surveillance
    https://dynamed.ebscohost.com/about/about-us: The FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions.
    N Engl J Med
    .
    2007;356:1915-1927.


    10/23/2009 DynaMed's Systematic Literature Surveillance
    https://dynamed.ebscohost.com/about/about-us: FDA approves new indication for Gardasil to prevent genital warts in men and boys. US Food and Drug Administration website. Available at:
    http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm187003.htm. Updated April 17, 2013. Accessed May 31, 2013.


    1/19/2010 DynaMed's Systematic Literature Surveillance
    https://dynamed.ebscohost.com/about/about-us: Recommended immunization schedules for persons aged 0 Through 18 years—United States, 2010.
    MMWR. 2010;58(51&52):1-4.


    6/4/2010 DynaMed's Systematic Literature Surveillance
    https://dynamed.ebscohost.com/about/about-us: FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP).
    MMWR. 2010;59(20):626-629.


    1/4/2011 DynaMed's Systematic Literature Surveillance
    https://dynamed.ebscohost.com/about/about-us: US Food and Drug Administration. Gardasil approved to prevent anal cancer. US Food and Drug Administration website. Available at:
    http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm237941.htm.
    Updated April 18, 2013. Accessed May 31, 2013.